贝伐珠单抗在恶性脑水肿治疗中的应用

Journal of International Oncology(2017)

Cited 0|Views0
No score
Abstract
以贝伐珠单抗为主的抗血管生成药物通过减少血管通透性和血脑屏障破坏,能有效减轻恶性脑水肿,缓解临床症状,改善患者生命质量。贝伐珠单抗在治疗恶性脑水肿方面取得了积极的疗效,因此被认为是治疗恶性脑水肿的一种安全、有效的治疗手段。
More
Translated text
Key words
Vascular endothelial growth factors,Brain edema,Brain neoplasms,Bevacizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined